CoChat
Sign Up
Cited by 5Substance Abuse Treatment and OutcomesMental Health Treatment and AccessForensic Toxicology and Drug Analysis

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey

Open access
Więckiewicz, Gniewko, Marek, Julia, Stokłosa, Iga, Szafoni, Sandra, Pluta, Szymon, Smukowska, Katarzyna, Żebrowska, Gabriela, Stokłosa, Maciej, Gorczyca, Piotr, Pudlo, Robert·2023·Medicina
DOI 10.3390/medicina59050908PMC PMC10221474
Open this paper in CoChat — free accountOpen PDF

Abstract

Background and Objectives: PolDrugs is the largest Polish naturalistic nationwide survey to present basic demographic and epidemiological data that could potentially prevent harm from illicit substances intake in drugs users. The most recent results were presented in 2021. The goal of this year’s edition was to re-present the above data and compare it to the previous edition’s data to identify and describe the differences. Materials and Methods: The survey included original questions about basic demographics, substance use, and psychiatric treatment. The survey was administered via the Google Forms platform and promoted via social media. The data was collected from 1117 respondents. Results: People of all ages use a variety of psychoactive substances in many situations. The three most commonly used drugs are marijuana, 3,4-methylenedioxymethamphetamine, and hallucinogenic mushrooms. The most common reason for seeking professional medical help was amphetamine use. A total of 41.7 percent of respondents were receiving psychiatric treatment. The three most common psychiatric diagnoses among the respondents were depressive disorders, anxiety disorders, and ADHD. Conclusions: Key findings include increases in the use of psilocybin and DMT, increases in the use of heated tobacco products, and a near doubling in the percentage of individuals receiving psychiatric help in the past two years. These issues are discussed in the discussion section of this paper, which also addresses the limitations to the article.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/medicina59050908

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. (2023, February 16). Science In Poland—Polish Press Agency. Available online: https://scienceinpoland.pap.pl/en/news/news%2C86807%2Caverage-polish-drug-user-24-year-old-male-large-city-finds-shocking-new-survey.html.

Cited by

Sorted by citations

See all 5

Related

See all

Metadata

Authors
Więckiewicz, G., Marek, J., Stokłosa, I., Szafoni, S., Pluta, S., Smukowska, K., Żebrowska, G., Stokłosa, M., Gorczyca, P., & Pudlo, R.
Affiliations
  • Medical University of Silesia (PL)
  • Social Drug Policy Initiative, 02-662 Warsaw, Poland
  • Department of Psychoprophylaxis, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland
Corresponding author
Więckiewicz, Gniewko
ORCID
Venue
Medicina
Publisher
MDPI AG
Published
2023-05-09
Volume
59
Issue
5
Pages
908
ISSN
  • 1010-660X (ISSN-L)
  • 1648-9144
DOI
10.3390/medicina59050908
PMC
PMC10221474
OpenAlex
W4378515555
Cited by
5
References
11
Citations by year
2025: 1 · 2024: 3 · 2023: 1
FWCI
0.99
Type
journal article
Language
en
Open access
Licence
Locations
  • Medicina (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Uniwersytet Śląski w Katowicach
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
psychiatric treatment, drug use, drug users, cannabis, MDMA, psilocybin, DMT, heated tobacco products, depressive disorders, anxiety disorders, attention deficit hyperactivity disorder, amphetamine use, illicit drug use trends
MeSH terms
Hallucinogens, Humans, Poland, Surveys and Questionnaires, Substance-Related Disorders, Drug Users

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review